Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advax-adjuvanted seasonal influenza vaccine in adults with chronic disease or older age
ACTRN12608000364370Phase 2Completed
- Sponsor
- Vaxine
- Start
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of Advax-adjuvanted trivalent inactivated influenza vaccine in influenza (2 arms), sponsored by Vaxine. Primary endpoints: Immunogenicity and Safety. Started Apr 2008; status: completed.
02
Drugs
Advax-adjuvanted trivalent inactivated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12608000364370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000364370.